As the COVID-19 outbreak gets more severe with increasing death toll, Verdict has conducted two polls to find out the confidence levels about the development of an effective vaccine and treatment for coronavirus over the next 12 months.
The first poll, which measured the confidence over a vaccine development, was run between 26 March and 01 April. Analysis of the poll results indicated high confidence in approximately 52% of the respondents, while 28.5% were moderately confident.
Confidence about an effective coronavirus vaccine development was poor in 19.6% of the respondents, as illustrated in the chart.
The poll analysis was based on more than 1,500 responses received during the period. The second poll, run between 02 April and 06